Trials / Completed
CompletedNCT03496844
Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma
A Pilot Study of F-18 Fluciclovine-PET/CT as A Diagnostic Tool for Bone Metastases in Patients With Hormonal Sensitive and Resistant Prostate Adenocarcinoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- University of Arizona · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Determine diagnostic accuracy of Axumin-PET positive bone lesion by confirmatory bone biopsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | F-18 fluciclovine-PET/CT scan | PET/CT imaging with F-18 fluciclovine |
Timeline
- Start date
- 2018-04-15
- Primary completion
- 2021-04-27
- Completion
- 2021-04-27
- First posted
- 2018-04-12
- Last updated
- 2022-08-16
- Results posted
- 2022-08-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03496844. Inclusion in this directory is not an endorsement.